CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS (UNAUDITED) - USD ($) $ in Thousands	3 Months Ended		12 Months Ended
	Mar. 31, 2025	Mar. 31, 2024	Dec. 31, 2024
Cash Flows From Operating Activities:
Net loss	$ (6,603)	$ (11,394)
Adjustments to reconcile net loss to net cash used in operating activities:
Foreign currency	(22)	(49)
Depreciation	36	191
Amortization	876	1,697
Non-cash lease expense	77	54
Inventory step up amortization	100	0
Stock-based compensation	2,089	3,366
(Gain) Loss on extinguishment of debt and accounts payable	(3,037)	1,066
Loss on settlement of accounts payable	551	0
Interest Income	(158)	0
Non-cash interest expense	1,306	671
Amortization of debt discount	370	1,329
Common stock issued to lender in connection with entering Equity Line of Credit Agreement	0	368
Change in fair value of convertible notes	573	316
Loss on issuance of warrants	0	345
Change in fair value of derivatives	1,487	(54)
Change in fair value of warrants	(449)	(1,799)
Changes in operating assets and liabilities
Accounts receivable	(338)	(42)
Inventories	391	(130)
Prepaid expenses and other current assets	(48)	198
Vendor deposits	(37)	46
Other assets	0	5
Accounts payable	(580)	123
Accrued expenses and other current liabilities	(35)	936
Deferred revenue	(11)	(146)
Operating lease liabilities	(83)	(56)
Net cash used in operating activities	(3,545)	(2,959)
Cash Flows From Investing Activities:
Loan to Sportstech	(2,025)	0
Acquisition of business, cash paid, net of cash acquired	0	(1,447)
Acquisition of software and content	(166)	(263)
Net cash used in investing activities	(2,191)	(1,710)
Cash Flows From Financing Activities:
Payments of loans	0	(135)
Payments of related party loans	0	(240)
Redemption on convertible notes	0	(90)
Proceeds from issuance of convertible notes, net of issuance costs	2,678	4,756
Proceeds from issuance of common stock from At the Market Offering, net of issuance costs	1,594	0
Proceeds from exercise of incremental warrants and issuance of convertible notes, net of issuance costs	3,499	0
Proceeds from the issuance of common stock from equity line of credit	0	324
Net cash provided by financing activities	7,771	4,615
Effect of exchange rate on cash	34	54
Net Change In Cash and Cash Equivalents	2,069	0
Cash and restricted cash at beginning of the period	138	0	$ 0
Cash and restricted cash at end of period	2,207	0	$ 138
Supplemental Disclosure Of Cash Flow Information:
Cash paid for interest	88	0
Non-Cash Investing and Financing Information:
Property & equipment in accounts payable	18	18
Inventories in accounts payable and accrued expenses	205	650
Issuance of common stock and series B preferred stock for the acquisition of business	0	3,702
Issuance and offering costs in accounts payable and accrued expenses	43	69
Issuance of preferred stock through conversion of debt	0	10,082
Subscription receivable for issuance of Series A Preferred Stock for modification of loan	0	3,000
Gain on extinguishment of debt with related party	279	0
Issuance of common stock upon conversion of convertible notes	5,798	866
Issuance of Series C Preferred Stock upon settlement of loss restoration agreement	3,127	0
Issuance of common stock from convertible notes and conversion of debt	0	547
Issuance of warrants with convertible notes	1,213	0
Issuance of embedded derivatives with convertible notes	2,104	0
Stock-based compensation capitalized in intangible asset and other assets	334	220
Series A Preferred Stock [Member]
Non-Cash Investing and Financing Information:
Dividends Paid in Kind	225	0
Series C Preferred Stock [Member]
Non-Cash Investing and Financing Information:
Dividends Paid in Kind	$ 253	$ 0